FluMist

STN: 125020 Proper Name: Influenza Vaccine Live, Intranasal Tradename: FluMist Manufacturer: MedImmune, LLC Indications: For active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. FluMist is approved for use in persons 2 through 49 years of age. Product Information Package Insert and Information for Patients - FluMist Supporting Documents July 1, 2025 Approval Letter - FluMist September 20, 2024 Approval Letter - FluMist August 6, 2024 Approval Letter - FluMist July 9, 2020 Approval Letter - FluMist Supporting Documents older than three years - FluMist